Literature DB >> 32941676

Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease.

Jillian Price1, Carey Escheik1,2, Ali Weinstein3, Patrice Winter1,2, Lynn Gerber1, Zobair Younossi1,2.   

Abstract

People with Hepatitis C (HCV) and non-alcoholic fatty liver disease (NAFLD) in the United States follow national trends toward a sedentary lifestyle and are increasingly at risk for hypertension. The intent of this study was to identify potential correlates of exercise tolerance in people with two types of chronic liver disease (CLD)-NAFLD and HCV. Measures included cardiac output, oxygen consumption and stroke volume, blood pressure, distance walked in 6 minutes, clinical laboratory tests, and medications influencing the autonomic nervous system, patient self-reports of activity, fatigue, and health-related quality of life (HRQL). A total of 67 patients completed the 6-minute walk test [45.1% Female, Age 51.7 ± 8.0 years, Body Mass Index 32.8 ± 5.9, 60% HCV]. At baseline, 70% had either diastolic (DBP) or systolic blood pressure outside normal range. Performance and cardiorespiratory measures correlated strongly with one another, but not with activity. Patients with abnormal DBP reported significantly lower maximum activity (MAS; r = -.254, P = .041, CI = -0.51 to -0.010; MAS 70.6 vs 82.5), significantly higher DBP post-6-minute walk test (r = .524, P = .0001, CI = 0.287-0.762) and significantly lower overall HRQL items related to physical domains (r = .273, P = .029, CI = -0.518 to -0.029). Mental-domain HRQL and depression measures did not correlate significantly with blood pressure. This study reports a significant correlation between both pre-hypertensive and hypertensive DBP, poor physical-domain self-reports, HRQL, and performance in CLD patients.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  activity; blood pressure; chronic liver disease; performance

Mesh:

Year:  2020        PMID: 32941676      PMCID: PMC8029773          DOI: 10.1111/jch.13938

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  48 in total

1.  Heart rate recovery: validation and methodologic issues.

Authors:  K Shetler; R Marcus; V F Froelicher; S Vora; D Kalisetti; M Prakash; D Do; J Myers
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

Review 2.  Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention.

Authors:  Ileana L Piña; Carl S Apstein; Gary J Balady; Romualdo Belardinelli; Bernard R Chaitman; Brian D Duscha; Barbara J Fletcher; Jerome L Fleg; Jonathan N Myers; Martin J Sullivan
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

3.  Estimation of VO2max from the ratio between HRmax and HRrest--the Heart Rate Ratio Method.

Authors:  Niels Uth; Henrik Sørensen; Kristian Overgaard; Preben K Pedersen
Journal:  Eur J Appl Physiol       Date:  2003-11-18       Impact factor: 3.078

Review 4.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  2011 Compendium of Physical Activities: a second update of codes and MET values.

Authors:  Barbara E Ainsworth; William L Haskell; Stephen D Herrmann; Nathanael Meckes; David R Bassett; Catrine Tudor-Locke; Jennifer L Greer; Jesse Vezina; Melicia C Whitt-Glover; Arthur S Leon
Journal:  Med Sci Sports Exerc       Date:  2011-08       Impact factor: 5.411

6.  Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort.

Authors:  C R Cole; J M Foody; E H Blackstone; M S Lauer
Journal:  Ann Intern Med       Date:  2000-04-04       Impact factor: 25.391

7.  Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease.

Authors:  Z M Younossi; G Guyatt; M Kiwi; N Boparai; D King
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

8.  Prevalence and trends in obesity among US adults, 1999-2008.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Lester R Curtin
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

9.  Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment.

Authors:  Paschalis Paschos; Konstantinos Tziomalos
Journal:  World J Hepatol       Date:  2012-12-27

10.  Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Noreen Hossain; Arian Afendy; Maria Stepanova; Fatema Nader; Manirath Srishord; Nila Rafiq; Zachary Goodman; Zobair Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-25       Impact factor: 11.382

View more
  1 in total

1.  Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease.

Authors:  Jillian Price; Carey Escheik; Ali Weinstein; Patrice Winter; Lynn Gerber; Zobair Younossi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-17       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.